18Oct 2018

PRIMARY MALIGNANT MELANOMA OF NASAL FOSSAE (A CASEREPORT).

  • Service d?Onco- Radioth?rapie CHU Mohammed VI, Marrakech.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Primary malignant melanoma of nasal fossaeis a rare tumor, they represent 3 to 4% of sinonasal cancers. The diagnosis of nasosinus malignant melanoma remains late given the absence of specific clinical signs and risk factors, it is confirmed by the anatomopathological examination.The immunohistochemistry reinforces the diagnosis in thepresence of any achromic varieties or those simulating an undifferentiated tumour or neurinoma.Computed tomography(CT) and magnetic resonance imaging (MRI) is a prerequisite for local and general pretherapeutic evaluation.Surgery is the main indication witha large excision by external approach.There is no consensusregarding post-operative attitude, however in recent studies adjuvant external radiotherapy would provide better local control.Chemotherapyremains in force in the metastatic forms. The prognosis ofMalignant melanoma of nasal fossae remains pejorative with a 10 to 40% survival rate of 5 years. We report a case of primary malignant melanoma of nasal fossae treated inthe service of onco-radiotherapy university hospital of Marrakech.

  1. Bhave CG, Ogale SB, Sane SY. Malignant melanoma of the nasal cavity (a case report). J Postgrad Med. 1990; 36(3):173-174. This article on PubMed
  2. Kharoubi S. Malignant melanoma of nasal fossae: clinical and therapeutic considerations about three cases. Cancer Radiother. 2005 Mar;9(2):99-103. This article on PubMed
  3. Prasad ML, Perez-Ordonez B. Nonsquamous Lesions of the Nasal Cavity, Paranasal Sinuses, and Nasopharynx. In :Gnepp DR. Diagnostic surgical pathology of the head and neck. Saunders Elsevier : Philadelphia, 2009: 111-189
  4. Ferraro RE, Schweinfurth JM, Highfill GR. Mucosal Melanoma of the Sinonasal Tract, Am J Otolaryngol2002; 23:321-323.
  5. Simon C, Toussaint B, Coffinet L. Tumeurs malignes des cavit?s nasales et paranasales, Encycl M?d Chir. Elsevier, Paris. Oto-rhino-laryngologie 1997 :20-405-A-10. 19p.
  6. Bridger AG, Smee D, Baldwin MAR, Kwok B, Bridger GP. Experience with mucosal melanoma of the nose and paranasal sinuses, ANZ J Surg 2005;75:192-197.
  7. Poissonnet G, Castillo L, Dassonville O, Ettore F, Birtwisle-Peyrottes I, Santini J, Demard F. Les m?lanomes malins nasosinusiens : revue de la litt?rature ? propos de 12 cas. RevLaryngolOtolRhinol. 1997 ; 118(3):155-61. PubMed | Google Scholar
  8. Castillo L, Poissonnet G, haddad A, Dassonville O, Santini J,Demard F. M?lanomes malins nasosinusiens : bilan et strat?gie th?rapeutique. Cahiers ORL 1998 ; XXXIII : 426-32.
  9. BOUFILS P., BRASNU D., MENARD M. et autres.Les tumeurs des fosses nasales.Etude r?trospective d'une s?rie de 67 cas.Ann. Oto-Laryng., (Paris), 1989, 106, 225-231.
  10. DELEON J., BENITEZ J., CASTANEDA F. et autres. M?lanomamaligno de las fosas nasales dos casos de nuestraexp?riencia. Annales O.R.L., Iber-Amer 1993, XX, 3, 279-287.
  11. THOMPSON A.C., MORGAN D.A.L., BRADLEY P.J.Malignant melanoma of the nasal cavity and peranasal sinuses. Clin. Oto-Laryngol., 1993, 18, 34-36.
  12. Haguenauer JP, Gignoux B, Bailly C. M?lanomes malins cervicofaciaux. EMC ORL chir Cervico Fac. 1990 ; 20- 950(10):7-10. PubMed | Google Scholar
  13. Medina JE, Ferlito A, Pellitteri PK, Shaha AR, Khafif A. Current management of mucosal melanoma of the head and neck. J Surg Oncol. 2003; 83(2):116-22. PubMed | Google Scholar
  14. ASSIMAKOPOULOS D., SKEVAS A., KASTANIOUDAKIS Y., BAI M.Les m?lanomes cutan?s de la r?gion cervico-faciale. Rev. Stomatol-Chir. Maxillo-fac., 1992, 93, n? 5, 318-323.
  15. Nakashima JP, Vi?gas CM, Fassizoli AL, Rodrigues M, et al. Postoperative adjuvant radiation therapy in the treatment of primary head and neck mucosal melanomas. ORL J OtorhinolaryngolRelat
  16. Lund VJ, Howard DJ, Harding L, Wei WI. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope. 1999; 109(2 Pt 1):208-11. PubMed | Google Scholar
  17. Laraqui Janah Nz, Ait Benhamou C, Detsouli M, BenghalemA, Chekkouri I, Benchekroun Y. Le m?lanome malin des fossesnasales. Med Maghreb 1995 n?50.
  18. Sasse AD, Sasse EC, Clark LG, Ulloa L, Clark OA. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma. Cochrane Database Syst Rev. 2007 Jan; (1):CD005413. PubMed | Google Scholar
  19. Kasper B, D'Hondt V, Vereecken P, Awada A. Novel treatment strategies for malignant melanoma: a new beginning? Crit Rev Oncol Hematol. 2007; 62(1):16-22. PubMed | Google Scholar
  20. Martin JM, Porceddu S, Weih L, Corry J, Peters LJ. Outcomes in sinonasalmucosalmelanoma, ANZ J Surg 2004;74:838-842.
  21. Malard O, Brasnu D. Tumeurs malignes rhinosinusiennes. In : Trait? d?ORL. EditionsM?decine Sciences Flammarion, Paris.2008 ; 34 :241-248.
  22. Tartour E, Dorval T, Mosseriv L, Mathiot C, Brailly H, Montero F,et al. Serum interleukin6 and C-reactive protein leves correlate withresistance to IL-2 therapy and poor survival in melanoma patients. BrJ Cancer 1996;5:911?3.
  23. Yii NW, Eisen T, Nicolson M, A?Hern R, Rhys-Evan P. Mucosal MalignantMelanoma of the Head and Neck: the Marsden Experience over half a century, Clin Oncol 2003;15:199-204.

[N. Bouzid, K.diakite, I.lalya, A. Elomrani and M. Khouchani. (2018); PRIMARY MALIGNANT MELANOMA OF NASAL FOSSAE (A CASEREPORT). Int. J. of Adv. Res. 6 (Oct). 1288-1292] (ISSN 2320-5407). www.journalijar.com

bouzid nawal
Service d’Onco- Radiothérapie CHU Mohammed VI, Marrakech

DOI:

Article DOI: 10.21474/IJAR01/7936      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7936

Download Full Paper

Download PDF No. of Downloads: 8 | No. of Views: 44